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Abstract
Background: Serotonin syndrome is rarely, potentially life threatening condition, associated with use of serotonin acting medications and psychoactive drugs. In 
the majority of cases the symptoms occur soon after the initiation of a new drug or a change in the dose. Objective: To present a case report and to describe the 
possible mechanism of development of serotonin syndrome during the interactions between milk thistle seeds and methadone on hepatic cytochrome enzyme 
system P450. Methods: A case report of a young man on regular therapy with methadone, who develop a serotonin syndrome after ingestion a high dose of 
milk thistle seeds. Results: Commercial preparations of milk thistle include the extract silibinin, which exhibits no beneficial or harmful drug interactions at 
normal doses, but at higher concentrations it can lead to dose-dependent effects on methadone metabolism, through inhibition of CYP3A4 and P-glycoprotein. 
As a result, it may lead to enhanced serotonin re-uptake inhibition and increased serotonin activity. Discussion: Milk thistle is widely used and recommended 
for detoxification, but it may have serious and life threatening interactions with psychotropic drugs and psychoactive substances when used in high doses. 
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Introduction
Serotonin syndrome (SS) is a rare, potentially life threatening, 
condition, associated with the use of serotonin-acting medications 
and psychoactive drugs. The mechanism of the formation of SS is 
via postsynaptic hyperstimulation of 5-hydroxytryptamine (5-HT) 
2A and 1A serotonin receptors in the central and peripheral nervous 
system. In the majority of cases the symptoms occur soon after the 
initiation of a new drug or a change in the dose. The classic triad of 
symptoms are: altered mental status (confusion, excitement, agitation, 
hallucinations), autonomic dysfunction (tachycardia, tachypnea, 
fever, diaphoresis) and neuromuscular abnormalities (tremor, 
hyperreflexia, clonus, myoclonus). SS is usually self-limited once the 
iniciting drug has been discontinued1,2. 
Case report
A 51-years old male with psychoactive substance use disorder, who 
was on methadone substitution therapy (200 mg daily) for 15 years, 
was admitted to a psychiatric unit for confusion and fluctuating 
levels of agitation. Before the admission he had been observed at the 
emergency department after experiencing restlessness, palpitations, 
dyspnea and resting tremor in the last 24 hours. ECG, laboratory 
tests and physical examination did not show any abnormalities, 
except high blood pressure (200/120 mmHg), and tachycardia 
and tachypnea. He admitted using milk thistle seeds regularly for 
some time, but in the last three days he took a full fist of seeds 
daily in an attempt to “detoxify” his liver because of regular alcohol 
consumption. At the emergency department he was disoriented, 
confused and agitated, with hallucinations and he was consequently 
transferred to the psychiatric ward. Upon admission he was still 
confused, with high blood pressure and tachycardia. Restlessness, 
hallucinations and neuromuscular symptoms (tremor of the hands 
and jaw, myoclonus, hyperreflexia) were also observed. Alcohol 
and drug screening-tests were negative. Supportive measures and 
a sedative agents were introduced (lorazepam 2.5 mg). After three 
hours, the symptoms resolved completely. 
Discussion
A possible mechanism of the development of SS was through 
interaction on the hepatic drug-metabolizing enzyme system 
cytochrome P450. Methadone is a serotonin re-uptake inhibitor, 
metabolized by cytochrome P450, mostly by CYP3A43. In vitro 
studies of methadone show a greater tendency toward serotonin 
reuptake inhibition compared with other opiates, which may 
explain methadone-mediated precipitation of SS4. Milk thistle is 
widely used for several medical conditions, especially for liver 
diseases. Commercial preparations of milk thistle include the extract 
silymarin, consisting of various flavonolignans, including silibinin, 
which have been shown to inhibit the in vitro activity of several 
cytochrome P450 enzymes including CYPP3A45. Silibinin exhibits 
no harmful drug interactions at normal doses (200-900 mg/day), but 
at higher concentrations it can lead to clinical important drug-drug 
interactions through inhibition of CYP3A4 and P-glycoprotein6. 
Results from in vitro studies on rats have indicated dose-dependent 
effects of silibinin on methadone metabolism, resulting in 50 to 100 
percent reduction in methadone metabolism, which can lead to 
enhanced serotonin re-uptake inhibition and increased serotonin 
activity7,8.
Conclusion
The interactions between milk thistle seeds and methadone need 
further investigations and more attention is recommended in patients 
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